You can try to understand this, I sure don’t.


https://www.nature.com/articles/s41429-021-00491-6

What I gather overall is that ivermectin is an anti-inflammatory so it potentially slows a downhill snowball of side effects before it starts.  It possibly blocks certain pathways in a cell or protein where an RNA virus would be expected to enter and replicate.  And it possibly has a strong enough ionic charge or something that it somehow penetrates the virus membrane or cell wall and destroys or inactivates it.

Suspected issues/unknowns are dosage and application method, as you want the ivermectin in the mucous tissues? and lungs.

If you can’t tell, it’s a bit above my head.  It sounds ripe for research and it sounds like widespread use without targeted research and formulations and sites of action could be like antibacterial soap or 10oz 2-pass glyphosate chemical programs  - a great sounding idea that creates downstream harder issues to solve.